Table 2.
Univariate analysis of the efficacy assessment after one session of hemoporfin-mediated photodynamic therapy
| Independent variables | Noneffective treatment, n (%) | Effective treatment, n (%) | Z/χ2 | P |
|---|---|---|---|---|
| Age | 19.077 | 0.580 | ||
| Sex | 0.112 | 0.573738 | ||
| Male | 8 (12.3) | 12 (18.5) | ||
| Female | 20 (30.8) | 25 (38.5) | ||
| Treatment history | 3.494 | 0.062 | ||
| None | 21 (32.3) | 34 (52.3) | ||
| PDL | 7 (10.8) | 3 (4.6) | ||
| Types of PWSs | 3.478 | 0.062 | ||
| Pink | 15 (23.1) | 28 (43.1) | ||
| Purple | 13 (20.0) | 9 (13.8) | ||
| Hypertrophic | 0 (0.0) | 0 (0.0) | ||
| Lesion distribution | ||||
| Proximal | 5 (7.7) | 19 (29.2) | 8.428 | 0.038 |
| Middle | 12 (18.5) | 16 (24.6) | ||
| Distal | 5 (7.7) | 2 (3.1) | ||
| Mixed parts | 4 (6.2) | 2 (3.1) | ||
| Vascular pattern | ||||
| I | 1 (1.5) | 7 (10.8) | 9.915 | 0.019 |
| II | 22 (33.8) | 10 (15.4) | ||
| III | 11 (16.9) | 6 (9.2) | ||
| IV | 3 (4.6) | 5 (7.7) |